Clinical Trials on Macrosomia, Fetal in Australia

Total 51 results

Monash University
National Health and Medical Research Council, Australia; Cerebral Palsy Alliance and other collaborators

Recruiting

Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction (PROTECTMe)

Fetal Growth Retardation | Pregnancy Preterm | Stillbirth and Fetal Death

Australia, New Zealand
South Australian Health and Medical Research Institute
Women's and Children's Hospital, Australia; Flinders Medical Centre; Royal North... and other collaborators

Active, not recruiting

Prenatal Iodine Supplementation and Early Childhood Neurodevelopment (PoppiE)

Pregnancy Related | Neurodevelopmental Disorders | Nutrition Disorder, Fetal

Australia
Shiphrah Biomedical Inc.
University of South Australia

Terminated

UniSA BackOff! Study: Adelaide PrenaBelt Trial

Pregnancy Complications | Fetal Growth Retardation | Sleep-Disordered Breathing | Infant, Very Low Birth Weight | Stillbirth | Infant, Small for Gestational Age | Fetal Hypoxia | Infant, Low Birth Weight

Australia
Monash University

Completed

Melatonin to Prevent Brain Injury in Unborn Growth Restricted Babies

Fetal Growth Retardation

Australia
Monash Medical Centre
Monash University

Recruiting

FASST - Fetal Alcohol Spectrum Stimulant Trial (FASST)

Fetal Alcohol Spectrum Disorders

Australia
Medical University of Vienna
The Obstetrics and Gynaecology Clinic Narodni Front

Withdrawn

Core-temperature Monitoring in Patients With PPROM

Preterm Premature Rupture of Fetal Membranes

Austria
Fogarty Sarah
Massage Therapy Foundation; University of Western Sydney

Recruiting

Massage as an Adjunct Approach to Care for Pregnant Women Who Have Experienced a Stillbirth

Pregnancy Related | Pregnancy Loss

Australia
Medical University of Vienna

Unknown

Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants

Intrauterine Growth Restriction | Neurodevelopmental Disorder | EEG; Spikes, Centrotemporal, Epilepsy of Childhood | Premature - Weight 1000g-2499g or Gestation of 28-37weeks

Austria
Edgar Jaeggi
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)

Fetal Atrial Flutter Without Hydrops | Fetal Supraventricular Tachycardia Without Hydrops | Fetal Supraventricular Tachycardia With Hydrops

United States, Canada, Germany, Australia, Netherlands, United Kingdom
St Vincent's Hospital Melbourne
Monash University; The Queen Elizabeth Hospital; The University of Queensland; BiomeBank...

Recruiting

Microbial Restoration in Inflammatory Bowel Diseases (MIRO II)

Inflammatory Bowel Diseases | Crohn Disease | Microbiome | Fecal Microbiota Transplantation

Australia
Medical University of Vienna

Completed

Do Prostheses of SphinkeeperTM Migrate After Operation?

Fecal Incontinence

Austria
McMaster University
Canadian Institutes of Health Research (CIHR)

Terminated

Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)

Venous Thromboembolism | Fetal Death

Australia, Canada
Medical University of Vienna

Completed

SphinkeeperTM Procedure for Treating Severe Faecal Incontinence

Faecal Incontinence

Austria
Orphatech Pharmaceuticals, GmbH

Withdrawn

Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A

Molybdenum Cofactor Deficiency Type A

Australia
Bond Biosciences

Terminated

A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers

Hereditary Hemochromatosis

Australia
Medical University of Vienna

Completed

Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)

Coronary Artery Disease | Ischemic Heart Disease | Heavy Metal Toxicity

Austria
A.M.I. Agency for Medical Innovations GmbH

Recruiting

Safety and Performance of a Silicone Implant for Fecal Incontinence Treatment (SimplyFI)

Fecal Incontinence

Spain, Austria, Germany
Medical University of Vienna

Unknown

mtDNA as Novel Biomarker for Intra-amniotic Infection (mtDNA)

Preterm Premature Rupture of Membrane

Austria
Medical University of Graz

Recruiting

Fetal Haemoglobin and Cerebral and Peripheral Oxygenation. (HbFIN)

Preterm Birth | Oxygen Toxicity | Fetal Hemoglobin

Austria
Medical University of Vienna

Recruiting

Best Surgical Technique for Optimal Lead Placement in Sacral Neuromodulation - a Comparative Cadaver Study

Faecal Incontinence

Austria
Murdoch Childrens Research Institute
Melbourne Health; Austin Health; Royal Brisbane and Women's Hospital; The University... and other collaborators

Completed

Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary? (Mi-iron)

Hereditary Haemochromatosis

Australia
MedtronicNeuro

Completed

Sacral Nerve Stimulation for Anal Incontinence and Bowel Control (MDT-301)

Fecal Incontinence and Constipation

United States, Denmark, Spain, Sweden, Netherlands, Austria, Germany, United Kingdom
St Vincent's Hospital Melbourne

Completed

The Multi-disciplinary Treatment of Functional Gut Disorders Study (MANTRA)

Functional Dyspepsia | Irritable Bowel Syndrome | Constipation - Functional | Faecal Incontinence | Functional Abdominal Pain Syndrome | Other Rome IV Functional Gastrointestinal Disorders

Australia
Medical University of Graz
Bristol-Myers Squibb

Terminated

The IRMI-FMT Trial

Malignant Melanoma Stage III | Malignant Melanoma Stage IV | Fecal Microbiota Transplantation

Austria
BioCeryx
University of British Columbia; University College London Hospitals; Brugmann... and other collaborators

Unknown

Automated Screen for Fetal Aneuploidy (FAST1)

Trisomy 21 and Other Fetal Aneuploidy

Australia, United Kingdom, Spain, Canada, Belgium, Portugal
Janssen Research & Development, LLC

Completed

A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn

Erythroblastosis, Fetal | Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)

United States, Canada, Netherlands, Belgium, Australia, Germany, Spain, Sweden, United Kingdom
Medical University of Vienna

Active, not recruiting

Circulating miRNAs and Bone Microstructure in Adults With Hypophosphatasia

Bone Diseases, Metabolic | Bone | Hypophosphatasia

Austria
University Hospital, Gasthuisberg
The University of Texas Health Science Center, Houston; Baylor College of Medicine and other collaborators

Completed

Fetal Surgery for Moderate Left Sided Congenital Diaphragmatic Hernia. (TOTAL moderate)

Congenital Diaphragmatic Hernia | Pulmonary Hypoplasia | Fetal Surgery

United Kingdom, Canada, United States, Belgium, Germany, Italy, France, Australia, Poland, Spain
Origin Biosciences

Completed

Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP

Molybdenum Cofactor Deficiency, Type A

United States, Australia, Netherlands, United Kingdom, Tunisia
The Hospital for Sick Children
Labatt Family Heart Centre

Recruiting

Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia (FAST Registry)

Atrial Flutter | Tachycardia, Supraventricular | Tachycardia, Atrioventricular Nodal Reentry | Tachycardia Atrial | Tachycardia, Reciprocating | Tachycardia, Paroxysmal | Fetal Hydrops | Tachycardia, Atrial Ectopic

United States, Hong Kong, Canada, Netherlands, Sweden, Australia, Brazil, Finland, France, Russian Federation, Spain, Czechia, Switzerland, United Kingdom
Innovacell AG

Recruiting

Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence (Fidelia)

Fecal Incontinence

Japan, France, Sweden, Bulgaria, Spain, Austria, United Kingdom, Germany, Czechia, Italy
Origin Biosciences

Completed

A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)

Molybdenum Cofactor Deficiency

United States, Australia, United Kingdom, Germany, Netherlands, Turkey
Alexion Pharmaceuticals

Completed

A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)

Hypophosphatasia (HPP)

United States, Taiwan, United Kingdom, Australia, Canada, Germany, Spain
La Jolla Pharmaceutical Company
PRA Health Sciences

Completed

A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis

Hereditary Hemochromatosis

United States, Australia, France, United Kingdom
Orthopedic Hospital Vienna Speising

Completed

Foot Disorders in X-linked Hypophosphatemia

X-linked Hypophosphatemia

Austria
Alexion Pharmaceuticals

Completed

Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)

Hypophosphatasia (HPP)

United States, France, United Kingdom, Canada, Netherlands, Russian Federation, Turkey, Australia
Alexion Pharmaceuticals

Completed

Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)

Hypophosphatasia

United States, Spain, Australia, United Kingdom, Italy, France, Canada, Germany, Japan, Russian Federation, Saudi Arabia, Turkey
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

Iron Overload | Hereditary Hemochromatosis

United States, Germany, Italy, Australia, Canada, France
Actelion

Terminated

Persistent Pulmonary Hypertension of the Newborn (FUTURE 4)

Persistent Pulmonary Hypertension of the Newborn

United States, Australia, Belgium, Czech Republic, France, Germany, Korea, Republic of, Poland, Russian Federation, Singapore, Switzerland, United Kingdom
Queen Silvia Children's Hospital, Gothenburg, Sweden
Sahlgrenska University Hospital, Sweden; Swedish Heart Lung Foundation

Recruiting

Effect of Fetal Aortic Valvuloplasty on Outcomes (FASSprosp)

Aortic Valve Stenosis | Congenital Heart Disease | Hypoplastic Left Heart Syndrome | Fetal Cardiac Disorder

United States, Austria, Canada, Finland, Germany, Poland, Spain, Sweden
Alexion Pharmaceuticals, Inc.

Recruiting

Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa (CHESTNUT)

Hypophosphatasia

United States, Japan, Italy, Germany, Turkey, India, Australia, United Kingdom, Argentina, France, Canada
Alexion Pharmaceuticals, Inc.

Recruiting

Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase Alfa (HICKORY)

Hypophosphatasia

Italy, Spain, Korea, Republic of, Belgium, Germany, United States, China, France, Taiwan, Austria, Japan, India, Australia, Argentina, Israel, Poland, Turkey, Brazil, Thailand, United Kingdom, Canada, Slovakia, Czechia
Alexion Pharmaceuticals, Inc.

Not yet recruiting

Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP (MULBERRY)

Hypophosphatasia

United States, Taiwan, Thailand, Vietnam, United Kingdom, Korea, Republic of, Israel, Italy, Australia, Turkey, France, Poland, Germany, Spain, Belgium, China, Canada, Brazil, Argentina, Mexico
Alexion

Enrolling by invitation

Registry of Patients With Hypophosphatasia

Hypophosphatasia (HPP)

France, Poland, United Kingdom, Germany, Spain, Saudi Arabia, United States, Canada, Russian Federation, Australia, Italy
Alexion

Terminated

Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease

Wilson Disease

United States, France, Germany, Spain, Canada, Singapore, Poland, Denmark, Hungary, Australia, Austria, Czechia, Hong Kong, Israel, Japan, Korea, Republic of, New Zealand, Russian Federation, Serbia, Taiwan, Turkey, United Kingdom
Alexion Pharmaceuticals, Inc.

Terminated

Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease

Wilson Disease

Spain, Korea, Republic of, France, Germany, Japan, Australia, Poland, United Kingdom
Alexion Pharmaceuticals

Completed

Efficacy and Safety Study of WTX101 (ALXN1840) in Adult Wilson Disease Patients

Wilson Disease

United States, Germany, Austria, Poland, United Kingdom
Alexion

Completed

The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment

Wilson Disease

United States, Germany, Austria, Poland, United Kingdom
Kyowa Kirin Pharmaceutical Development Ltd

Active, not recruiting

Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age

X-linked Hypophosphatemia (XLH)

Sweden, Spain, United Kingdom, Italy, Austria, France
Kyowa Kirin, Inc.
Kyowa Kirin Co., Ltd.

Completed

Efficacy and Safety of Burosumab (KRN23) Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)

X-Linked Hypophosphatemia

Korea, Republic of, Canada, United States, Australia, Japan, United Kingdom, Sweden

Clinical Trials on Macrosomia, Fetal in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations